New Psychoactive Stubstances

Last updated on June 22nd, 2026 at 03:32 pm

New psychoactive substances are reshaping the drug supply faster than regulation can keep up, and that volatility makes both overdose and recovery harder to navigate. We will explain what these substances are, how they are grouped, and which ones are surging now, from nitazene opioids and xylazine to designer benzodiazepines and branded street mixtures. We will cover how clinicians and communities can detect and respond to them, what immediate steps reduce harm if exposure is suspected, and where professionals can find credible surveillance. Because these drugs complicate detox and raise relapse and overdose risk, we will also look at how Carrara Treatment supports recovery for people whose substance use involves an unpredictable, adulterated supply, with the privacy and clinical depth that situation demands.

What Are New Psychoactive Substances (NPS) and Why Do They Matter?

New psychoactive substances, often shortened to NPS, are drugs that fall outside existing international drug conventions yet still carry major health risks. They tend to emerge quickly, are frequently sold as legal highs or research chemicals, and can cause overdoses, psychosis, and organ failure. Part of what makes them so dangerous is that their composition and potency shift constantly, so a product sold under the same name can vary enormously from one batch to the next. Understanding the main categories helps clinicians, patients, and families recognize the dangers early and adapt recovery and harm-reduction strategies to a supply that does not hold still.

1. Synthetic Cannabinoids

Synthetic cannabinoids are man-made chemicals sprayed onto plant material and marketed as safe, legal alternatives to cannabis, often under names like spice or herbal incense. In reality they bear little resemblance to marijuana in either their effects or their danger. Because they bind far more strongly to the brain’s cannabinoid receptors, they can trigger seizures, psychosis, dangerous changes in heart rhythm, and in some cases sudden death. Their potency is wildly unpredictable from batch to batch, and contamination with other toxic compounds is common, which is exactly why treating them as a harmless substitute for cannabis is so hazardous.

2. Synthetic Opioids

Synthetic opioids are often far stronger than heroin or morphine, and this category includes fentanyl, its many analogs, and newer compounds that keep appearing in the illicit supply. Their extreme potency is what makes them so lethal: a difference of a few specks of powder can separate a typical dose from a fatal one, causing respiratory failure with little warning. They are frequently pressed into counterfeit pills or mixed into other drugs without the user’s knowledge, so people regularly take them without realizing it. That combination of strength and disguise drives waves of overdoses worldwide and makes emergencies especially difficult to manage.

3. Synthetic Cathinones

Synthetic cathinones are stimulants commonly sold as bath salts, and they can produce extreme agitation, paranoia, and dangerous overheating known as hyperthermia. Examples such as mephedrone and alpha-PVP have become notorious for provoking violent or erratic behavior, organ damage, and lasting psychological distress that can outlast the drug itself. Like other NPS, they are designed to skirt drug laws, so as one compound is banned another slightly altered version appears to take its place. The result is a moving target of stimulants whose effects are hard to predict and whose risks are frequently underestimated by the people taking them.

4. Benzodiazepine Analogs

Benzodiazepine analogs are sedatives engineered to mimic prescription anti-anxiety drugs, and compounds such as etizolam can cause blackouts and fatal overdoses, particularly when combined with alcohol or opioids. A crucial and dangerous distinction sets them apart from opioids: their effects cannot be reversed with naloxone, so the medication that rescues an opioid overdose does nothing for the sedation these drugs cause. That makes any overdose involving them more complex and riskier to manage. Because they are often mixed into other substances or sold as counterfeit pills, people may not even know a benzodiazepine analog is involved when an emergency unfolds.

5. Plant-Derived and Mixed Adulterants

This category covers plant-derived stimulants like khat alongside the adulterants and toxic mixtures increasingly found in the street supply, including xylazine-laced opioids and branded blends sold under names like grey death or purple heroin. These additions make an already unpredictable supply far more dangerous, because the user has no way to know what is actually in a given product. Adulterants also complicate both drug testing and medical treatment, since standard screens may miss them and standard overdose responses may not fully work. Toxic mixtures of this kind are a major driver behind recent surges in overdose deaths and emergency hospitalizations.

How Are NPS Classified and What Substances Are Most Common Today?

Beyond knowing the broad categories, it helps to understand how the NPS supply is actually shifting right now, because the specific substances in circulation change rapidly. The overall direction is toward greater potency and heavier adulteration: more powerful opioids, more unpredictable mixtures, and more compounds engineered specifically to stay a step ahead of regulation and routine drug testing. The sections below look at what is surging within each category today, which is what most often turns up in seizures, toxicology screens, and emergency responses, and they set the stage for the substance-specific guidance that follows.

Synthetic Opioids

The most urgent current trend in this category is the rise of nitazenes, a class of synthetic opioids that includes isotonitazene, butonitazene, and brorphine and that can equal or surpass fentanyl in strength. Having appeared in the illicit supply only in recent years, they are spreading quickly because they are cheap to make and easy to disguise. They frequently turn up in counterfeit pills or mixed into powders without the user’s knowledge, so people are exposed to opioids many times stronger than they expect. This escalation in potency is the single biggest reason overdoses in this category have become so deadly and so hard to reverse with a single dose of naloxone.

Synthetic Cannabinoids

Within synthetic cannabinoids, the trend is one of constant reinvention. As specific compounds are identified and banned, manufacturers tweak the chemistry to create new versions that fall outside current laws, so the products on the street are rarely the same from year to year. These newer generations often bind even more aggressively to cannabinoid receptors, producing severe agitation, psychosis, seizures, and cardiac effects. Periodic outbreaks of mass poisonings, sometimes traced to a single contaminated batch, are a recurring feature of this market, and they tend to cluster in particular regions or communities before the supply shifts again.

Synthetic Cathinones

Synthetic cathinones follow a similar pattern of continual replacement, with newer stimulants stepping in as older ones such as alpha-PVP and mephedrone are scheduled and restricted. The compounds currently circulating can be more potent and longer-lasting than the ones they replace, which raises the risk of severe paranoia, hyperthermia, and prolonged psychiatric symptoms. Because they are often sold in colorful packaging as bath salts, plant food, or research chemicals, buyers rarely know which specific cathinone they are getting. That uncertainty has kept emergency-department visits tied to these stimulants persistently high even as the named products change.

Benzodiazepine Analogs

Designer benzodiazepines are an increasingly common feature of today’s supply, and etizolam in particular shows up both on its own and mixed into the opioid supply. The worrying trend is their growing presence in counterfeit pills sold as legitimate prescription medications, so someone expecting a familiar anti-anxiety pill may receive a far stronger or unpredictable analog instead. When these compounds are combined with opioids, they deepen sedation and respiratory depression in ways naloxone cannot reverse. Their spread adds a hidden layer of risk to an opioid supply that is already dangerous, and it complicates both overdose response and detox.

Plant-Derived and Mixed Adulterants

The defining adulteration trend of recent years is xylazine, a veterinary sedative now widely mixed into the opioid supply to extend its effects, along with newer agents in the same drug family. Branded polysubstance blends sold under names like grey death or purple heroin combine multiple potent compounds into a single unpredictable product. These mixtures are spreading because they are cheap to produce and difficult to detect, and they carry risks that a single substance would not, including wounds, prolonged sedation, and overdoses that respond only partially to standard treatment. This shift toward heavily adulterated, multi-drug products is one of the most dangerous features of the current supply.

What Should Clinicians Know About Nitazenes Like Butonitazene and Isotonitazene?

Nitazenes are highly potent synthetic opioids that, as a narrative review of the drug class describes, were first synthesized in the late 1950s as experimental analgesics but never approved for medical use because of their narrow safety margin. Many are reported to be hundreds to thousands of times stronger than morphine, and some exceed fentanyl. Isotonitazene has been detected in fatal overdoses and is frequently mixed with stimulants such as cocaine, which compounds the risk, while butonitazene is widely available online and carries the same dangers of respiratory depression, altered heart rate, loss of consciousness, and death.

From a clinical standpoint, a major challenge is that standard toxicology screens often miss nitazenes, which can delay both diagnosis and appropriate treatment. Clinicians should treat suspected opioid toxicity with naloxone while anticipating the need for repeated or higher dosing, because the extreme potency of these compounds can overwhelm a single standard dose. Close monitoring for re-sedation is essential, since the effects can outlast an initial naloxone response, and teams should account for likely polysubstance exposure that may call for additional supportive care and airway management. Suspecting nitazenes early, even without confirmation, can be lifesaving.

Is Etizolam Safer Than Prescription Benzodiazepines?

No. Etizolam is a designer benzodiazepine, technically a thienodiazepine, that is prescribed medically in a few countries such as Japan and Italy but is not approved for any medical use in the United States. Sold illicitly as tablets, powders, or counterfeit pills, it is linked to hallucinations, agitation, profound sedation, and overdose, with the danger rising sharply when it is combined with opioids or alcohol. It is also considerably potent, with a small dose roughly equivalent to a much larger dose of diazepam, and like other benzodiazepines its effects will not be reversed by naloxone.

Because illicit etizolam tablets and powders vary widely in dose and may contain additional depressants, no one taking them can be confident about their strength or contents. Medical management centers on supportive care and airway protection rather than a specific antidote. Flumazenil, the drug that can reverse benzodiazepine effects, is used only cautiously and when clearly indicated, because it can provoke seizures in people who are dependent on benzodiazepines or who have taken multiple substances. For anyone using etizolam regularly, a medically supervised taper is far safer than abrupt cessation, given the genuine risk of dangerous withdrawal.

How Dangerous Are Grey Death, Smurf Dope, and Purple Heroin?

These branded street mixtures are dangerous precisely because their contents are unknown and inconsistent. Depending on the batch, they may contain heroin or methamphetamine combined with fentanyl, carfentanil, brorphine, or other potent adulterants, in proportions that vary from one sale to the next. Their visual appearance offers no reliable guide: a concrete-like grey color or a vivid blue tint says nothing dependable about what is actually inside or how strong it is. Treating the look of a product as a safety signal is a serious and sometimes fatal mistake, because two batches that appear identical can differ enormously in potency.

Overdoses involving these mixtures often present with cyanosis, or bluish skin, along with snoring respirations, unresponsiveness, and respiratory failure. The right response is to treat the situation as a suspected opioid overdose, giving naloxone while preparing for multiple doses and for advanced airway support, since the potency involved can require far more than a single intervention. Because the composition of these blends shifts rapidly and varies widely by region, clinicians and harm-reduction workers should expect the unexpected and avoid assuming that what worked in one case will be enough in the next.

What Are the Risks of Khat, Lean, and Tianeptine/Tianaa?

Several substances that are sometimes seen as milder or more socially acceptable still carry real risks. Khat is a plant stimulant with effects similar to amphetamines, and at high doses it can induce psychosis and aggression. Lean, which blends prescription codeine cough syrup with soda and candy, is marketed in a way that appeals to young people but remains an addictive opioid mixture with genuine overdose potential. Tianeptine, sold in gas stations and online as a supplement or research chemical under names like Tianaa, acts on opioid receptors and has caused severe dependence and difficult withdrawal. The details below outline the specific risks of each.

• Khat: Stimulant effects include euphoria, tachycardia, and insomnia; chronic use may lead to psychological dependence and psychosis-like symptoms.
• Lean (codeine mixtures): Respiratory depression risk increases with alcohol or benzodiazepines; dependence and withdrawal are common.
• Tianeptine/Tianaa: Associated with hospitalization, multi-system effects, and rapid tolerance; some overdoses may respond to naloxone due to opioid receptor activity.

Why Is Xylazine in the Drug Supply and How Should Overdoses Be Managed?

Xylazine is a veterinary sedative that is increasingly mixed into the opioid supply to prolong or deepen sedation, creating what is known on the street as tranq dope. According to the CDC, the share of fatal opioid overdoses involving xylazine rose roughly 276 percent between early 2019 and mid-2022, climbing from about 3 percent to nearly 11 percent. Like medetomidine, xylazine belongs to the alpha-2 adrenergic agonist class and shares similar sedative properties, although medetomidine is more commonly used in veterinary anesthesia. Xylazine does not respond to naloxone, but naloxone should still be given for suspected co-occurring opioids, followed by supportive measures for low blood pressure, slow heart rate, and profound central nervous system depression.

The complications of xylazine extend beyond sedation. Chronic use is associated with severe skin ulcers and tissue death at and around injection sites, wounds that can be disfiguring and slow to heal, and the deep sedation it causes often outlasts the effect of any opioids taken alongside it. Management therefore emphasizes diligent wound care, fluids, and vasopressor support when blood pressure drops, along with harm-reduction counseling that includes safer-use supplies and a clear path into treatment. Because xylazine is so often present without the user’s knowledge, raising awareness and expanding testing are central to reducing its harms.

How Can Communities Detect and Respond to Rapidly Emerging NPS?

Because the NPS supply changes so quickly, communities are best protected by coordinated surveillance, flexible clinical protocols, and rapid public alerts working together. Early warning systems, hospital and poison-center data, wastewater testing, and forensic laboratories can together identify emerging trends and trigger a response before harms escalate. No single data source captures the whole picture, so the goal is to connect them into a system that notices a dangerous new substance early and gets that information to clinicians and the public quickly. The steps below outline how that capacity is built.

1. Build Local Early Warning Capacity

Effective early warning starts with data-sharing among the people who see drug harms first: emergency medical services, emergency departments, medical examiners, and public health agencies. Linking their information makes it possible to detect clusters of overdoses, track which adulterants are appearing, and push out timely alerts before a local spike becomes a crisis. Integrating qualitative reports from outreach workers and drug-checking services adds a street-level view that formal data often lags behind, capturing shifts in the supply as they happen. Together these inputs let a community guide targeted interventions toward the substances and neighborhoods that need them most.

2. Expand Drug Checking and Test Availability

Drug checking gives people who use drugs, and the clinicians who treat them, real information about what is actually circulating. Communities can support this with validated laboratory methods and by distributing fentanyl and xylazine test strips where doing so is legal. It is important to pair these tools with clear guidance about their limitations, since a negative strip does not guarantee safety, and to encourage practices like using a small test dose first. The findings from drug checking also feed back into the system, informing public alerts, clinical training, and outreach messaging tailored to the specific dynamics of the local supply.

3. Standardize Clinical Protocols

Hospitals and clinics respond more effectively when they are not improvising in the moment. Standardized protocols for high-potency opioid overdoses, prolonged sedation, and mixed intoxications give clinicians a clear playbook when an unfamiliar or unusually strong substance arrives. Useful protocols include explicit guidance on repeated naloxone dosing, airway management, the wound and sedation complications of xylazine, and the particular challenges of benzodiazepine analog exposure. Because the supply keeps changing, order sets and staff training need to be revisited regularly as new compounds appear and the evidence on how to manage them continues to evolve.

4. Scale Harm Reduction and Treatment Linkage

Detection and protocols matter most when they connect people to help. That means expanding access to naloxone, safer-use supplies, and same-day medications for opioid use disorder, so the moment someone is ready for treatment is not lost to a waiting list. Co-locating wound care and behavioral health support with outreach services meets people where they are, which is especially important given the skin wounds associated with xylazine. Throughout, nonjudgmental and respectful messaging is what actually engages people who use drugs, lowering the barriers that otherwise keep them from ongoing care, monitoring, and eventually recovery.

5. Communicate Clearly to the Public

Public communication works best when it is concise, specific, and free of stigma. An effective alert describes the substances that have been observed, the effects people should expect, and the concrete steps they can take to stay safer. Avoiding stigmatizing language is not just a matter of tone, because messaging that shames people discourages the very help-seeking the alert is meant to encourage. Including the symptoms that should prompt an immediate 911 call, along with links to local services and credible national resources, builds the trust that makes people more likely to act on the information and reach out when they or someone near them is in danger.

What Immediate Steps Reduce Harm if NPS Exposure Is Suspected?

If someone is showing signs of an overdose, the priorities are immediate and simple: call emergency services, administer naloxone in case opioids are involved, and monitor their breathing closely. Placing the person in the recovery position helps protect their airway, and it is important to resist the temptation to give other substances in an attempt to counteract the drug. Even if the person seems to improve, they still need medical evaluation, because many NPS are long-acting or unknown in composition and can cause re-sedation or delayed toxicity hours later, after the initial crisis appears to have passed.

A few practical habits meaningfully reduce risk for anyone who may encounter these substances. Keeping multiple doses of naloxone on hand matters because potent synthetic opioids often require more than one, and using fentanyl and xylazine test strips where they are permitted can reveal hidden adulterants. Starting with a small test dose, never using alone, and saving a sample of the product for possible testing can all inform both immediate care and broader public alerts. Connecting with local harm-reduction services provides not only supplies and education but also a direct link to treatment when someone is ready to take that step.

Where Can Professionals Find Credible Guidance and Surveillance on NPS?

Clinicians and public health teams are most effective when they align their local protocols with current advisories and evidence summaries, and when they collaborate across healthcare, public health, law enforcement, and community organizations so that new knowledge translates into practice quickly. The faster credible information moves between these groups, the faster a community can respond to a dangerous shift in the supply. For programs focused on whole-person healing, complementary approaches such as therapeutic sound bath practices can support the stress regulation and engagement that help people stay in care alongside standard medical treatment.

To stay current, professionals can rely on poison control center updates, the United Nations Office on Drugs and Crime Early Warning Advisory on new psychoactive substances, and regional public health alerts that track NPS trends, toxicology, and clinical management. These sources provide the shared situational awareness that improves triage and shortens the time to appropriate care. Keeping that awareness current is what allows clinicians and communities to respond to market shifts before harms escalate, rather than discovering a dangerous new substance only after a wave of overdoses has already begun.

What Makes Carrara Rehab’s Ultra-Luxury Approach the Right Fit for Discerning Clients?

At Carrara Rehab, we deliver an ultra-luxury, highly confidential treatment experience in Malibu, built for clients who expect the very best. Our model combines evidence-based therapies, holistic healing, and resort-level amenities to support deep, sustainable recovery without forcing anyone to sacrifice comfort, privacy, or lifestyle. From personalized care plans and a high staff-to-client ratio to spa-caliber wellness services and serene, discreet settings, we create a sanctuary where healing the mind, body, and spirit is both clinically effective and genuinely comfortable, which matters enormously when someone is facing the hard work of recovery.

We design every detail around individual needs, from private suites and gourmet chef-prepared cuisine to integrative therapies such as CBT, EMDR, yoga, acupuncture, and cranial sacral therapy. Our low-census model ensures meaningful one-on-one time with clinicians, while our wellness programming, including fitness coaching, nutrition, mindfulness, and bodywork, reinforces long-term health. For high-profile clients, confidentiality is built directly into our protocols and our environments, allowing genuine progress without public scrutiny. The result is a path to wellness that feels restorative, dignified, and deeply personalized rather than clinical and impersonal.

Who We Serve

We support clients who require strict privacy, prefer a holistic and evidence-based model, and want comfort without compromise during treatment. For many of them, especially those in the public eye, the combination of genuine discretion and serious clinical depth is what finally makes seeking help feel possible. That understanding shapes every part of how the program is delivered, from who they interact with to how their information is protected, so the focus can stay entirely on recovery.

• High-profile confidentiality: We maintain rigorous privacy standards for celebrities, executives, public figures, and individuals in elite circles, enabling focused, uninterrupted recovery.
• Fully personalized plans: We tailor care to psychological, emotional, and physical needs, integrating trauma-informed therapy with complementary modalities for comprehensive healing.
• Luxury without compromise: We pair clinical excellence with spa-level amenities, including private suites, fitness, pools, and restorative bodywork, to reduce stress and enhance engagement in treatment.

How Our Amenities Elevate Outcomes

We merge clinical quality with well-being rituals to improve readiness, resilience, and retention in care. The aim is never comfort for its own sake, but comfort that does real clinical work, lowering the stress and physical strain that can otherwise pull someone out of treatment before it has a chance to take hold. When the body feels safe and cared for, the demanding emotional work of recovery becomes far more achievable, and clients are more likely to stay engaged through the difficult early weeks.

• Ultra-luxury services: Private rooms with ensuites, chef-driven menus, personal training, massage, facials, reflexology, and tranquil outdoor spaces support nervous-system regulation and recovery momentum.
• Holistic therapies: Yoga, mindfulness, acupuncture, reiki, sound baths, aromatherapy, and cranial sacral therapy complement CBT, EMDR, and trauma care, improving integration and stress tolerance.
• Comprehensive wellness: Nutrition counseling, structured fitness, and lifestyle optimization fortify long-term health and relapse resilience beyond discharge.

What Is Recovery Like at Carrara’s Malibu Residence?

Carrara’s recovery experience is delivered at a private oceanfront Malibu residence chosen so clients can heal in the setting where they feel most supported. Set against the Pacific, the environment is designed to promote nervous-system calm and deep restoration through nature, light, and open space, which many people find easier to settle into than a conventional clinical setting. The same clinical depth and hospitality-level service define every part of the stay, so the serenity of the location never comes at the expense of the seriousness of the care.

We meet you where you thrive, in a calming coastal sanctuary that maintains our hallmark discretion, personalized care, and integrated wellness. For clients who regulate best by the sea, immediate access to Malibu’s quiet rhythms supports the steadier baseline that recovery depends on, helping minimize triggers and sustain engagement in the program. Every element, from the clinical plan to the daily routine of the residence, is shaped around the individual, so the setting actively supports treatment rather than simply housing it. The result is privacy and personalization working together in one of the most restorative environments imaginable.

How Does Carrara Rehab Support Your Recovery?

Carrara Treatment addresses the core challenges of privacy, clinical complexity, and sustaining change by combining advanced clinical care with ultra-luxury hospitality in a discreet environment, so you can heal thoroughly while preserving your dignity and lifestyle. For someone whose substance use involves today’s unpredictable, adulterated supply, that depth of care matters even more, because recovery has to account for medical risk, relapse triggers, and the pressure to keep functioning while healing. Take the first step today to discuss a tailored plan and how Carrara Rehab can support lasting recovery in a serene, discreet setting built around the full picture of your life.

• Personalized clinical care: Treatment plans built around your specific history, goals, and clinical needs.
• Privacy and discretion: A confidential environment designed for clients who need their recovery protected.
• Holistic wellness support: Nutrition, fitness, mindfulness, and outdoor therapy integrated with evidence-based clinical care.